BC
Bain Capital Life Sciences
Private EquityActiveBain Capital Life Sciences Fund specializes in buyouts, inflection capital, growth capital, turnaround, and private equity investments.
25
Investments
9
Exits
$85B
AUM
36.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bain Capital Life Sciences.
Investment Thesis & Strategy
Bain Capital Life Sciences invests in various stages of fintech, biotech, healthcare, and crypto/Web3 companies, focusing on buyouts, inflection capital, growth capital, turnaround, and private equity opportunities.
Investment Activity
Deals per year over the last 7 years
3
20172
20182
20190
20201
20210
20224
2023Portfolio Companies
Selected investments from their portfolio of 25 companies
L
Latitude Bio
Biotech · Growth, 2023
N
Novo Holdings
Biotech · Growth, 2023
V
Vivani Medical
Biotech · Growth, 2023
C
Curia
Biotech · Growth, 2023
C
Cerevel Therapeutics
Biotech · Growth, 2021
A
Arvelle Therapeutics
Biotech · Growth, 2019
K
Kodiak Sciences
Biotech · Growth, 2019
C
Censa Pharmaceuticals
Biotech · Growth, 2018
E
Evotec
Biotech · Growth, 2018
B
Biohaven Pharmaceutical
Biotech · Growth, 2017
P
PAREXEL
Healthcare · Growth, 2017
S
Symphogen
Biotech · Growth, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
BioverativAcquisition2018$11.6B
ModernaIPO2018$7.5B
PAREXELAcquisition2017$4.5B
Sigma-AldrichAcquisition2015$17B
CatalentIPO2014$1.8B
PRA Health SciencesIPO2013$2.1B
QuintilesIMSIPO2013$10.5B
EvotecIPO1999—
AlkermesIPO1996—
Frequently Asked Questions
Bain Capital Life Sciences focuses on Series B, Series C+ stage investments.
Related Investors
Summit Partners
Boston, United States · 345 deals
TA Associates
Boston, United States · 129 deals
Fidelity Management and Research Company
Boston, United States · 122 deals
HarbourVest Partners
Boston, United States · 116 deals
Advent International
Boston, United States · 107 deals
Boston Millennia Partners
Boston, United States · 91 deals